No Data
No Data
Uncovering Potential: NRX Pharmaceuticals's Earnings Preview
ATAI Life Sciences Q1 EPS $(0.15) Beats $(0.18) Estimate, Sales $1.55M
Compass Pathways Analyst Ratings
Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency'
Chardan Capital Maintains Buy on Mind Medicine, Maintains $20 Price Target
Mind Medicine Analyst Ratings
Den the Dragon :


